Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

620 ARTÍCULOS , VIENDO DEL 391 AL 405

Advances in fluorescent probes for detection and imaging of amyloid-β peptides in Alzheimer's disease

Zhang Y, Ding C, Li C, Wang X.

Adv Clin Chem. 2021;103:135-190. doi: 10.1016/bs.acc.2020.08.008. Epub 2021 Feb 15.

Efficacy of antidepressant drugs in the treatment of depression in Alzheimer disease patients: A systematic review and network meta-analysis

He Y, Li H, Huang J, Huang S, Bai Y, Li Y, Huang W.

J Psychopharmacol. 2021 Aug;35(8):901-909. doi: 10.1177/02698811211030181. Epub 2021 Jul 9.

The approval of a disease-modifying treatment for Alzheimer's disease: impact and consequences for the nuclear medicine community

Garibotto V, Albert NL, Barthel H, van Berckel B, Boellaard R, Brendel M, Cecchin D, Ekmekcioglu O, van de Giessen E, Guedj E, Lammerstma AA, Semah F, Traub-Weidinger T, Van Weehaeghe D, Morbelli S; EANM Neuroimaging Committee.

Eur J Nucl Med Mol Imaging. 2021 Sep;48(10):3033-3036. doi: 10.1007/s00259-021-05485-y.

Aducanumab: What about the Patient?

Petersen RC.

Ann Neurol. 2021 Sep;90(3):334-335. doi: 10.1002/ana.26181. Epub 2021 Aug 7.

An Investigation of Levetiracetam in Alzheimer's Disease (ILiAD): a double-blind, placebo-controlled, randomised crossover proof of concept study

Sen A, Akinola M, Tai XY, Symmonds M, Davis Jones G, Mura S, Galloway J, Hallam A, Chan JYC, Koychev I, Butler C, Geddes J, Van Der Putt R, Thompson S, Manohar SG, Frangou E, Love S, McShane R, Husain M.

Trials. 2021 Jul 31;22(1):508. doi: 10.1186/s13063-021-05404-4.

Evolution of genetic testing supports precision medicine for caring Alzheimer's disease patients

Bruni AC, Bernardi L, Maletta R.

Curr Opin Pharmacol. 2021 Oct;60:275-280. doi: 10.1016/j.coph.2021.08.004. Epub 2021 Sep 3.

Aducanumab (Aduhelm) for Alzheimer's disease

Med Lett Drugs Ther. 2021 Jul 12;63(1628):105-106.

Chinese expert consensus statement for diagnosis and treatment of dementia with Lewy bodies 2020

Ji Y, Li YF, Peng DT, Chen ZC; Chinese Society of Geriatrics of Chinese Medical Association, Chinese Society of Microcirculation Neurodegenerative Diseases Committee.

Chin Med J (Engl). 2021 Oct 20;134(21):2529-2531. doi: 10.1097/CM9.0000000000001754.

Safety and efficacy of losartan for the reduction of brain atrophy in clinically diagnosed Alzheimer's disease (the RADAR trial): a double-blind, randomised, placebo-controlled, phase 2 trial

Kehoe PG, Turner N, Howden B, Jarutyte L, Clegg SL, Malone IB, Barnes J, Nielsen C, Sudre CH, Wilson A, Thai NJ, Blair PS, Coulthard E, Lane JA, Passmore P, Taylor J, Mutsaerts HJ, Thomas DL, Fox NC, Wilkinson I, Ben-Shlomo Y; RADAR investigators.

Lancet Neurol. 2021 Nov;20(11):895-906. doi: 10.1016/S1474-4422(21)00263-5.

[Disease-modifying treatment approaches for Alzheimer's disease]

Frölich L, Hausner L.

Nervenarzt. 2021 Dec;92(12):1239-1248. doi: 10.1007/s00115-021-01222-w. Epub 2021 Nov 4.

From structure to clinic: Design of a muscarinic M1 receptor agonist with potential to treatment of Alzheimer's disease

Brown AJH, Bradley SJ, Marshall FH, Brown GA, Bennett KA, Brown J, Cansfield JE, Cross DM, de Graaf C, Hudson BD, Dwomoh L, Dias JM, Errey JC, Hurrell E, Liptrot J, Mattedi G, Molloy C, Nathan PJ, Okrasa K, Osborne G, Patel JC, Pickworth M, Robertson N, Shahabi S, Bundgaard C, Phillips K, Broad LM, Goonawardena AV, Morairty SR, Browning M, Perini F, Dawson GR, Deakin JFW, Smith RT, Sexton PM, Warneck J, Vinson M, Tasker T, Tehan BG, Teobald B, Christopoulos A, Langmead CJ, Jazayeri A, Cooke RM, Rucktooa P, Congreve MS, Weir M, Tobin AB.

Cell. 2021 Nov 24;184(24):5886-5901.e22. doi: 10.1016/j.cell.2021.11.001.

Digging Deeper: Advancements in Visualization of Inhibitory Synapses in Neurodegenerative Disorders

Radulović S, Sunkara S, Maurer C, Leitinger G.

Int J Mol Sci. 2021 Nov 18;22(22):12470. doi: 10.3390/ijms222212470.

Dementia with non-convulsive seizures: a case report

Chen YS, Chen TS, Huang CW.

J Int Med Res. 2021 Dec;49(12):3000605211062453. doi: 10.1177/03000605211062453.

Repurposing Antihypertensive Drugs for the Management of Alzheimer's Disease

Law CSW, Yeong KY.

Curr Med Chem. 2021;28(9):1716-1730. doi: 10.2174/0929867327666200312114223.

Update and Potential Opportunities in CBP [Cyclic Adenosine Monophosphate (cAMP) Response Element-Binding Protein (CREB)-Binding Protein] Research Using Computational Techniques

Akinsiku OE, Soremekun OS, Soliman MES.

Protein J. 2021 Feb;40(1):19-27. doi: 10.1007/s10930-020-09951-8. Epub 2021 Jan 4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias